This OTA is to develop a cold stored platelet product with extended shelf life up to 21 days, which will significantly increase the availability of platelets to roles 2 and 3 in theater, decrease…
Ended Other Transaction Agreement Awarded Last action
- Contract number
- W81XWH2090021
- Awardee
-
The Washington University UEI L6NFUM28LQM5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $5,136,215
Award facts
- Contract value 99% obligated
- $5,212,240.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Other
- Place of performance
- University City, MO 63130, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$76,025 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$1 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$6,294,200 | |
| Funding Only Action | $6,294,200 | |
| Original award | $5,212,241 |
About this award
This is a $5,212,240.05 Other Transaction Agreement awarded by the Defense Health Agency to The Washington University in St. Louis, Missouri. The contract is to develop a cold-stored platelet product with an extended shelf life of up to 21 days, which will increase the availability of platelets for military use, decrease bacterial growth, and reduce platelet expiration. The award does not have a set-aside designation. The Washington University is a prominent private research institution that frequently supports federal research initiatives across multiple disciplines. The university has a significant portfolio of federal contract and grant awards, including a $149.9 million Indefinite Delivery Contract with the National Cancer Institute for genomic characterization services.
Description
This OTA is to develop a cold stored platelet product with extended shelf life up to 21 days, which will significantly increase the availability of platelets to roles 2 and 3 in theater, decrease bacterial growth, and reduce platelet expiration.
Quick answers
Who was awarded contract W81XWH2090021?
W81XWH2090021 was awarded to The Washington University by Defense Health Agency (Department of Defense) on September 25, 2020.
How much is contract W81XWH2090021 worth?
The government has obligated $5,136,215 on W81XWH2090021. Its current value, with exercised options, is $5,212,240.
Was contract W81XWH2090021 competed?
The extent of competition for W81XWH2090021 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award